Chen Jiaxi, Liu Yawen, Min Jingyu, Wang Huizhi, Li Feifan, Xu Chunhui, Gong Aihua, Xu Min
Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Jiangsu University Zhenjiang 212001, Jiangsu, China.
Department of Cell Biology, School of Medicine, Jiangsu University Zhenjiang 212013, Jiangsu, China.
Am J Cancer Res. 2021 Mar 1;11(3):624-639. eCollection 2021.
Alternative splicing (AS), a vital post-transcription process for eukaryote gene expression regulating, can efficiently improve gene utilization and increase the variety of RNA transcripts and proteins. However, AS of non-coding RNAs (ncRNAs) has not been paid enough attention to compared with that of protein-coding RNAs (mRNAs) for a long time. In fact, AS of ncRNAs, especially long noncoding RNAs (lncRNAs), also plays a significant regulatory role in the human disease. Recently, some bifunctional genes transcribed into both mRNA and lncRNA transcripts by AS have been observed. Here, we focus on the AS of lncRNAs and bifunctional genes producing lncRNA transcripts and propose a strategy for the future research of lncRNA AS.
可变剪接(Alternative splicing,AS)是真核生物基因表达调控中至关重要的转录后过程,它能够有效提高基因利用率,增加RNA转录本和蛋白质的多样性。然而,长期以来,与蛋白质编码RNA(mRNA)的可变剪接相比,非编码RNA(ncRNA)的可变剪接并未得到足够的关注。事实上,ncRNA的可变剪接,尤其是长链非编码RNA(lncRNA)的可变剪接,在人类疾病中也发挥着重要的调控作用。最近,人们观察到一些通过可变剪接同时转录生成mRNA和lncRNA转录本的双功能基因。在此,我们聚焦于lncRNA的可变剪接以及产生lncRNA转录本的双功能基因,并提出lncRNA可变剪接未来研究的策略。